We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The World Health Organization’s director-general has endorsed the voluntary sharing of patent rights and pooling of data to help develop COVID-19 drugs. Read More
The Indian government said Tuesday that it will lift its newly imposed export restriction on the anti-malaria drug hydroxychloroquine, a potential COVID-19 treatment. Read More
The European Medicines Agency yesterday announced a new system for reporting drug shortages and potential supply disruptions as the COVID-19 pandemic takes a toll on the stock of some critical medicines. Read More
President Trump has reached out to India’s Prime Minister Narendra Modi following India’s export freeze on the COVID-19 treatment hydroxychloroquine, calling for an exception to the country’s new restrictions. Read More
A coalition of more than 50 rheumatology and lupus organizations urged all 50 governors in a letter to ensure patient access to chloroquine and hydroxychloroquine, which are used to treat lupus and arthritis, as well as malaria and now COVID-19. Read More
A group representing the drug supply chain is strongly arguing that a proposed executive order to only supply drugs domestically could mean that Americans won’t have access to the drugs they need. Read More
Manufacturers need to provide two-week updates on any supply issues during the COVID-19 emergency and going forward, the FDA said in a new straight-to-final guidance. Read More
The FDA issued an emergency use authorization (EUA) for the anti-malaria drugs hydroxychloroquine sulfate and chloroquine phosphate, clearing the way for HHS to distribute millions of doses for COVID-19 patients. Read More